- Home
- CRGX vs CYH Comparison
CRGX vs CYH Comparison
Compare CRGX & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- CYH
- Stock Information
- Founded
- CRGX 2021
- CYH 1985
- Country
- CRGX United States
- CYH United States
- Employees
- CRGX N/A
- CYH N/A
- Industry
- CRGX
- CYH Hospital/Nursing Management
- Sector
- CRGX
- CYH Health Care
- Exchange
- CRGX Nasdaq
- CYH Nasdaq
- Market Cap
- CRGX 190.0M
- CYH 482.7M
- IPO Year
- CRGX 2023
- CYH 1991
- Fundamental
- Price
- CRGX $4.16
- CYH $3.33
- Analyst Decision
- CRGX Hold
- CYH Hold
- Analyst Count
- CRGX 7
- CYH 8
- Target Price
- CRGX $4.67
- CYH $4.27
- AVG Volume (30 Days)
- CRGX 586.4K
- CYH 2.4M
- Earning Date
- CRGX 08-11-2025
- CYH 07-23-2025
- Dividend Yield
- CRGX N/A
- CYH N/A
- EPS Growth
- CRGX N/A
- CYH N/A
- EPS
- CRGX N/A
- CYH N/A
- Revenue
- CRGX N/A
- CYH $12,653,000,000.00
- Revenue This Year
- CRGX $57.81
- CYH N/A
- Revenue Next Year
- CRGX N/A
- CYH $3.49
- P/E Ratio
- CRGX N/A
- CYH N/A
- Revenue Growth
- CRGX N/A
- CYH 1.05
- 52 Week Low
- CRGX $3.00
- CYH $2.24
- 52 Week High
- CRGX $25.45
- CYH $6.29
- Technical
- Relative Strength Index (RSI)
- CRGX 45.07
- CYH 51.63
- Support Level
- CRGX $4.33
- CYH $3.28
- Resistance Level
- CRGX $4.36
- CYH $3.56
- Average True Range (ATR)
- CRGX 0.19
- CYH 0.20
- MACD
- CRGX -0.04
- CYH -0.02
- Stochastic Oscillator
- CRGX 21.76
- CYH 50.00
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.